176 related articles for article (PubMed ID: 34132911)
1. Novel interstitial 2q12.3q13 microdeletion predisposes to developmental delay and behavioral problems.
Huynh MT; Gérard M; Ranguin K; Pichon O; Ghesh L; Alfallaj K; Joubert M; Bézieau S; Bénéteau C
Neurogenetics; 2021 Jul; 22(3):195-206. PubMed ID: 34132911
[TBL] [Abstract][Full Text] [Related]
2. Expanding the clinical phenotype at the 3q13.31 locus with a new case of microdeletion and first characterization of the reciprocal duplication.
Vuillaume ML; Delrue MA; Naudion S; Toutain J; Fergelot P; Arveiler B; Lacombe D; Rooryck C
Mol Genet Metab; 2013; 110(1-2):90-7. PubMed ID: 23920044
[TBL] [Abstract][Full Text] [Related]
3. Female patient with autistic disorder, intellectual disability, and co-morbid anxiety disorder: Expanding the phenotype associated with the recurrent 3q13.2-q13.31 microdeletion.
Quintela I; Gomez-Guerrero L; Fernandez-Prieto M; Resches M; Barros F; Carracedo A
Am J Med Genet A; 2015 Dec; 167A(12):3121-9. PubMed ID: 26332054
[TBL] [Abstract][Full Text] [Related]
4. Microduplication 3q13.2q13.31 identified in a male with dysmorphic features and multiple congenital anomalies.
Karavitakis E; Kitsiou-Tzeli S; Xaidara A; Kosma K; Makrythanasis P; Apazidou E; Kanavakis E; Tzetis M
Am J Med Genet A; 2014 Mar; 164A(3):666-70. PubMed ID: 24375959
[TBL] [Abstract][Full Text] [Related]
5. The emerging microduplication 3q13.31: Expanding the genotype-phenotype correlations of the reciprocal microdeletion 3q13.31 syndrome.
Hervé B; Fauvert D; Dard R; Roume J; Cognard S; Goidin D; Lozach F; Molina-Gomes D; Vialard F
Eur J Med Genet; 2016 Sep; 59(9):463-9. PubMed ID: 27568866
[TBL] [Abstract][Full Text] [Related]
6. The discovery of microdeletion syndromes in the post-genomic era: review of the methodology and characterization of a new 1q41q42 microdeletion syndrome.
Shaffer LG; Theisen A; Bejjani BA; Ballif BC; Aylsworth AS; Lim C; McDonald M; Ellison JW; Kostiner D; Saitta S; Shaikh T
Genet Med; 2007 Sep; 9(9):607-16. PubMed ID: 17873649
[TBL] [Abstract][Full Text] [Related]
7. Phenotypic and molecular characterization of 19q12q13.1 deletions: a report of five patients.
Chowdhury S; Bandholz AM; Parkash S; Dyack S; Rideout AL; Leppig KA; Thiese H; Wheeler PG; Tsang M; Ballif BC; Shaffer LG; Torchia BS; Ellison JW; Rosenfeld JA
Am J Med Genet A; 2014 Jan; 164A(1):62-9. PubMed ID: 24243649
[TBL] [Abstract][Full Text] [Related]
8. A novel microdeletion syndrome involving 5q14.3-q15: clinical and molecular cytogenetic characterization of three patients.
Engels H; Wohlleber E; Zink A; Hoyer J; Ludwig KU; Brockschmidt FF; Wieczorek D; Moog U; Hellmann-Mersch B; Weber RG; Willatt L; Kreiss-Nachtsheim M; Firth HV; Rauch A
Eur J Hum Genet; 2009 Dec; 17(12):1592-9. PubMed ID: 19471318
[TBL] [Abstract][Full Text] [Related]
9. Identification of a previously unrecognized microdeletion syndrome of 16q11.2q12.2.
Ballif BC; Theisen A; McDonald-McGinn DM; Zackai EH; Hersh JH; Bejjani BA; Shaffer LG
Clin Genet; 2008 Nov; 74(5):469-75. PubMed ID: 18811697
[TBL] [Abstract][Full Text] [Related]
10. A novel microdeletion syndrome at 3q13.31 characterised by developmental delay, postnatal overgrowth, hypoplastic male genitals, and characteristic facial features.
Molin AM; Andrieux J; Koolen DA; Malan V; Carella M; Colleaux L; Cormier-Daire V; David A; de Leeuw N; Delobel B; Duban-Bedu B; Fischetto R; Flinter F; Kjaergaard S; Kok F; Krepischi AC; Le Caignec C; Ogilvie CM; Maia S; Mathieu-Dramard M; Munnich A; Palumbo O; Papadia F; Pfundt R; Reardon W; Receveur A; Rio M; Ronsbro Darling L; Rosenberg C; Sá J; Vallee L; Vincent-Delorme C; Zelante L; Bondeson ML; Annerén G
J Med Genet; 2012 Feb; 49(2):104-9. PubMed ID: 22180640
[TBL] [Abstract][Full Text] [Related]
11. Neurodevelopmental disorders associated with dosage imbalance of ZBTB20 correlate with the morbidity spectrum of ZBTB20 candidate target genes.
Rasmussen MB; Nielsen JV; Lourenço CM; Melo JB; Halgren C; Geraldi CV; Marques W; Rodrigues GR; Thomassen M; Bak M; Hansen C; Ferreira SI; Venâncio M; Henriksen KF; Lind-Thomsen A; Carreira IM; Jensen NA; Tommerup N
J Med Genet; 2014 Sep; 51(9):605-13. PubMed ID: 25062845
[TBL] [Abstract][Full Text] [Related]
12. New cases and refinement of the critical region in the 1q41q42 microdeletion syndrome.
Rosenfeld JA; Lacassie Y; El-Khechen D; Escobar LF; Reggin J; Heuer C; Chen E; Jenkins LS; Collins AT; Zinner S; Babcock M; Morrow B; Schultz RA; Torchia BS; Ballif BC; Tsuchiya KD; Shaffer LG
Eur J Med Genet; 2011; 54(1):42-9. PubMed ID: 20951845
[TBL] [Abstract][Full Text] [Related]
13. Chromosome 2q12.3-q13 copy number variants in patients with neurodevelopmental disorders: genotype-phenotype correlation and new hotspots.
Aarabi M; Baumann J; Babcock M; Kessler E; Sebastian J; Madan-Khetarpal S; Hu J; Ou Z; Yatsenko S
Psychiatr Genet; 2022 Oct; 32(5):171-177. PubMed ID: 35837682
[TBL] [Abstract][Full Text] [Related]
14. Array CGH detection of a novel cryptic deletion at 3q13 in a complex chromosome rearrangement.
López-Expósito I; Ballesta-Martinez MJ; Bafalliu JA; Vera-Carbonell A; Domingo-Jiménez R; López-González V; Fernández A; Guillén-Navarro E
Genomics; 2014 Apr; 103(4):288-91. PubMed ID: 24607569
[TBL] [Abstract][Full Text] [Related]
15. Clinical and molecular characterization of an emerging chromosome 22q13.31 microdeletion syndrome.
Palumbo P; Accadia M; Leone MP; Palladino T; Stallone R; Carella M; Palumbo O
Am J Med Genet A; 2018 Feb; 176(2):391-398. PubMed ID: 29193617
[TBL] [Abstract][Full Text] [Related]
16. [Identification of a novel deletion region in 3q29 microdeletion syndrome by oligonucleotide array comparative genomic hybridization].
Seo EJ; Jun KR; Yoo HW; Yoo HK; Lee JO
Korean J Lab Med; 2010 Feb; 30(1):70-5. PubMed ID: 20197726
[TBL] [Abstract][Full Text] [Related]
17. Recurrent HERV-H-mediated 3q13.2-q13.31 deletions cause a syndrome of hypotonia and motor, language, and cognitive delays.
Shuvarikov A; Campbell IM; Dittwald P; Neill NJ; Bialer MG; Moore C; Wheeler PG; Wallace SE; Hannibal MC; Murray MF; Giovanni MA; Terespolsky D; Sodhi S; Cassina M; Viskochil D; Moghaddam B; Herman K; Brown CW; Beck CR; Gambin A; Cheung SW; Patel A; Lamb AN; Shaffer LG; Ellison JW; Ravnan JB; Stankiewicz P; Rosenfeld JA
Hum Mutat; 2013 Oct; 34(10):1415-23. PubMed ID: 23878096
[TBL] [Abstract][Full Text] [Related]
18. Further clinical and molecular delineation of the 15q24 microdeletion syndrome.
Mefford HC; Rosenfeld JA; Shur N; Slavotinek AM; Cox VA; Hennekam RC; Firth HV; Willatt L; Wheeler P; Morrow EM; Cook J; Sullivan R; Oh A; McDonald MT; Zonana J; Keller K; Hannibal MC; Ball S; Kussmann J; Gorski J; Zelewski S; Banks V; Smith W; Smith R; Paull L; Rosenbaum KN; Amor DJ; Silva J; Lamb A; Eichler EE
J Med Genet; 2012 Feb; 49(2):110-8. PubMed ID: 22180641
[TBL] [Abstract][Full Text] [Related]
19. 2q23.1 microdeletion identified by array comparative genomic hybridisation: an emerging phenotype with Angelman-like features?
Jaillard S; Dubourg C; Gérard-Blanluet M; Delahaye A; Pasquier L; Dupont C; Henry C; Tabet AC; Lucas J; Aboura A; David V; Benzacken B; Odent S; Pipiras E
J Med Genet; 2009 Dec; 46(12):847-55. PubMed ID: 18812405
[TBL] [Abstract][Full Text] [Related]
20. Delineation of the interstitial 6q25 microdeletion syndrome: refinement of the critical causative region.
Michelson M; Ben-Sasson A; Vinkler C; Leshinsky-Silver E; Netzer I; Frumkin A; Kivity S; Lerman-Sagie T; Lev D
Am J Med Genet A; 2012 Jun; 158A(6):1395-9. PubMed ID: 22585544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
